🇺🇸 FDA
Pipeline program

PA-824

NC-005-(J-M-Pa-Z)

Phase 2 small_molecule completed

Quick answer

PA-824 for Tuberculosis is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tuberculosis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials